Latest Share Purchase Plan News

Rox Resources has advanced its Youanmi Gold Project with a $27 million capital raise and a major drilling campaign, positioning the company for production by late 2025.

Kalamazoo Resources reports robust assay results from its Ashburton Gold Project and secures $1.13 million in capital to fuel ongoing exploration across Western Australia and Victoria.

Entyr Limited has launched a $9.5 million capital raising via a Share Purchase Plan and Placement Offer, aiming to recapitalize and return to ASX trading following its recent voluntary administration.

Pacgold Limited reports promising high-grade gold anomalies from a major aircore drilling campaign at its Alice River Gold Project, alongside strategic board appointments and a successful Share Purchase Plan to fuel further exploration.

Memphasys Limited marks a pivotal quarter with the completion of clinical trials for its Felix™ System, strategic market expansions in Greater China and the Middle East, and a successful capital raise to fuel growth.

Godolphin Resources reports significant drilling success at Lewis Ponds with thick massive sulphide intersections and advances its Narraburra Rare Earths project with high-value carbonate samples, supported by a strong capital raise.

Firebrick Pharma has made notable progress expanding its Nasodine nasal spray in Singapore, securing major distribution and marketing agreements that set the stage for retail sales growth in 2025.

RocketDNA has reported its strongest quarter yet, breaking the $2 million revenue barrier and marking its first international export of the xBot® autonomous drone platform to a major African mining operation.

Vulcan Energy has successfully closed its Share Purchase Plan, raising approximately A$8 million through the issuance of over 1.3 million new shares, following a major institutional placement. This capital injection supports the company’s pioneering lithium and renewable energy projects in Europe.

Sunstone Metals has unveiled a maiden 1.2Moz AuEq resource at El Palmar and a new gold-copper discovery at Bramaderos, supported by a $6.5 million capital raise and active partnership talks.

Zeus Resources has successfully placed the shortfall in its Priority Options Offer, bringing total funds raised to nearly $200,000. The move reflects solid shareholder backing ahead of the company’s next growth phase.

Anatara Lifesciences has successfully completed recruitment for the second stage of its pivotal GaRP-IBS clinical trial, with headline results expected in Q1 2025. The company also launched a new anti-obesity project and strengthened its cash position through recent capital raises.